Skip to main content
. 2016 Apr 22;7(24):36338–36352. doi: 10.18632/oncotarget.8916

Figure 8. MIR126 suppresses tumor formation.

Figure 8

A. Balb-c nu/nu mice were injected subcutaneously with 1×106 H28pRS or H28MiR126 cells and tumor growth was quantified by USI. The inset shows details of tumor size in the initial stage of the experiment. The results are derived from 6 mice in each group, and the symbol ‘*’ indicates significant differences with p<0.05. B. Shown here are representative images of tumors derived from the two H28 sublines acquired on individual days. C. Tumors from day 6 were sectioned and stained with H&E, as well as subjected to immunohistochemistry using anti-mesothelin IgG to identify MM cells in the sections and anti-Ki67 IgG to see the level of proliferation of tumor cells. H&E staining clearly documents lack of ‘structure’ of the H28MiR126 cell-derived tumors, which is obvious in tumors derived from cells transfected with the empty plasmid.